ArticleInternational journal of legal medicine2026
A systematic study of WGA strategies for enhanced STR and SNP genotyping on trace DNA.
Article in International journal of legal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The robust analysis of trace DNA (≤ 100 pg) remains a persistent challenge in forensic genetics, primarily due to the high failure rates and stochastic effects associated with conventional STR typing at low template quantities. Although whole genome amplification (WGA) offers a potential solution, its effectiveness and influencing factors in forensic applications still require systematic evaluation. This study comprehensively evaluated two prominent WGA methods-REPLI-g and MALBAC-for STR and SNP genotyping of trace DNA across a wide input range (0.2441-2000 pg) on both capillary electrophoresis (CE) and targeted next-generation sequencing (NGS). REPLI-g consistently produced high yields (average 37.40 μg) with excellent stutter stability (~ 0.1), proving optimal for intact to moderately degraded samples (≥ 31.25 pg). Although MALBAC yielded less, it demonstrated superior sensitivity for ultra-low inputs (< 20 pg), retaining 21.37% SNP accuracy even at 0.2441 pg. In general, on the NGS platform, both methods significantly increased sequencing depth and reduced allele drop-out at critical low inputs. By further exploring the factors influencing the effectiveness of WGA-based DNA genotyping, we identified amplicon length as a key factor, with effective amplification and typing achieved particularly when the amplified fragment length was ≤ 300 bp. These observations established an evidence-based framework for WGA selection in trace evidence typing. Combining a contextually chosen WGA method with targeted NGS and short-amplicon assays provides a promising workflow for recovering interpretable genotypes from single-source trace evidence that would otherwise be unanalyzable.
Indexed as
Identifiers
42118245What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.